News

Shares Of Glenmark Pharmaceuticals Jump 10% After Deal With AbbVie; USD 2 Billion To Commercialise Cancer & Autoimmune Diseases Healing Drug
Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to ...
ET Now on MSN17h
Glenmark Pharma shares hit 10% upper circuit after THIS news
In a regulatory filing made post-market hours on July 10, Glenmark announced that its wholly-owned step-down subsidiary, Ichnos Glenmark Innovation (IGI), has signed an exclusive worldwide licensing ...
BW Businessworld18h
Glenmark Pharma Stock At All-time After 10% Upper Circuit On Licensing Deal For Cancer Drug
Glenmark Pharma's stock surged 10 per cent to Rs 2,094, reaching the upper circuit during the initial trading session on 11 ...